-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Before the news of the medical network on March 15th, there are coronary stents, existing coronary dilatation balloons, and consumables such as artificial joints, spine and trauma are also on the way to collect.
.
.
.
.
1.
Start quotation
Start quotation
On March 13, Beijing Medical Centralized Purchasing Service Center, Tianjin Medical Purchasing Center, Hebei Medical Drugs and Equipment Centralized Purchasing Center jointly issued the "About the Convening of the Beijing-Tianjin-Hebei "3+N" Alliance Coronary Dilation Balloon Medical Consumables According to the notice of the "Communication Meeting of Enterprises for Procurement with Volume ", it is pointed out for all relevant companies that in order to do a good job in the procurement of medical consumables for coronary dilatation balloons in the Beijing-Tianjin-Hebei "3+N" alliance, it will be scheduled for March 2021 A corporate communication meeting was held on the 16th.
Notice that intends to participate in the Beijing, Tianjin and "3 + N" class alliance coronary balloon dilatation joint procurement of medical supplies with the amount of domestic or imported supplies manufacturer supplies the total domestic pharmnet.
com.
cn/agent_product/" target="_blank">agents , each company can send up to two delegates.
com.
cn/agent_product/" target="_blank">agents , each company can send up to two delegates.
At present, the official agency has started the collection of the price of coronary dilatation balloons from various related companies.
In view of the fact that the relevant companies have been in accordance with the Tianjin Medical Purchasing Center's March 9th "Notice on Carrying out the Centralized Filling of Information on Coronary Dilatation Balloon Medical Consumables" Fill in the price information;
In view of the fact that the relevant companies have been in accordance with the Tianjin Medical Purchasing Center's March 9th "Notice on Carrying out the Centralized Filling of Information on Coronary Dilatation Balloon Medical Consumables" Fill in the price information;
The alliance’s regional research decided to introduce the reported price to the “3+N” Alliance of Beijing-Tianjin-Hebei “3+N” Alliance Coronary Dilation Balloon Medical Consumables Linkage Purchase Project.
In principle, the price information declared by relevant companies in the previous period is the proposed supply price in the Beijing-Tianjin-Hebei "3+N" alliance area.
In principle, the price information declared by relevant companies in the previous period is the proposed supply price in the Beijing-Tianjin-Hebei "3+N" alliance area.
For companies that did not participate in the centralized reporting of price information in the previous period, they can supplement the report before 12:00 on March 14.
The supplementary price information and the earlier-filled price information will be imported into the Beijing-Tianjin-Hebei "3+N" Alliance Coronary Dilation Balloon Medical Consumables Cooperative Procurement Project.
The supplementary price information and the earlier-filled price information will be imported into the Beijing-Tianjin-Hebei "3+N" Alliance Coronary Dilation Balloon Medical Consumables Cooperative Procurement Project.
2.
The inter-provincial alliance is launched
The inter-provincial alliance is launched
On March 12, the official release of the "Notice on Carrying out the Related Work of the Beijing-Tianjin-Hebei "3+N" Alliance Coronary Expansion Balloon Medical Consumables Procurement Project".
Balloon, the structure is rapid exchange type, the first 15 digits of the National Medical Insurance Bureau medical insurance medical consumables code are C02020500200001 or C02020500200003, and the functional attributes include semi-compliant and non-compliant.
Balloon, the structure is rapid exchange type, the first 15 digits of the National Medical Insurance Bureau medical insurance medical consumables code are C02020500200001 or C02020500200003, and the functional attributes include semi-compliant and non-compliant.
Purchasing units are distinguished according to registration certificates and functional attributes.
The same purchasing unit includes all specifications and models.
The same purchasing unit includes all specifications and models.
In terms of procurement subjects, all public medical institutions (including military medical institutions) in Beijing, Tianjin, Hebei, Xinjiang, and the Corps formed a procurement alliance to implement joint procurement by volume.
Encourage medical insurance designated social medical institutions to actively participate.
Support the participation of medical institutions from other provinces (autonomous regions and municipalities) of the "3+N" Pharmaceutical Joint Procurement Alliance.
Encourage medical insurance designated social medical institutions to actively participate.
Support the participation of medical institutions from other provinces (autonomous regions and municipalities) of the "3+N" Pharmaceutical Joint Procurement Alliance.
The Beijing-Tianjin-Hebei Purchasing Center, as an agency for the procurement of coronary dilatation balloon medical consumables, relies on the Beijing-Tianjin-Hebei Pharmaceutical Joint Procurement Platform to be responsible for the specific implementation of project procurement.
The local medical security departments are responsible for formulating and implementing the implementation of the results of the territorial selection and supporting policies.
The local medical security departments are responsible for formulating and implementing the implementation of the results of the territorial selection and supporting policies.
This time, the procurement cycle of centralized delivery of coronary dilatation balloons is aligned with the procurement cycle of centralized delivery of coronary stents organized by the state.
The purchase agreement is signed for the first time for one year, and the purchase amount for renewal of the purchase agreement is determined on a pro rata basis in principle.
The purchase agreement is signed for the first time for one year, and the purchase amount for renewal of the purchase agreement is determined on a pro rata basis in principle.
During the purchase cycle, the purchaser will give priority to the use of this coronary dilatation balloon to purchase the selected products, and ensure that the agreed purchase amount is completed.
On this basis, the purchaser can purchase other appropriate coronary dilatation balloon products in an appropriate amount according to the relevant regulations of the province's centralized procurement management of medical consumables.
On this basis, the purchaser can purchase other appropriate coronary dilatation balloon products in an appropriate amount according to the relevant regulations of the province's centralized procurement management of medical consumables.
During the procurement cycle, the procurement entity completes the current contracted procurement volume, and the selected company still needs to supply the selected price at the selected price until the expiration of the procurement cycle.
During the procurement cycle, if the selected price for volume purchases in other regions is lower than the price selected for this volume linkage purchase, price linkage will be implemented.
During the procurement cycle, if the selected price for volume purchases in other regions is lower than the price selected for this volume linkage purchase, price linkage will be implemented.
3.
Linkage with prices in all provinces (autonomous regions and municipalities) across the country
Linkage with prices in all provinces (autonomous regions and municipalities) across the country
This time, the centralized procurement method of coronary dilatation balloons is volume linkage and two-way selection, that is, based on the use needs of the purchaser, referring to the overall market price level, comprehensive quality and other factors, linking the volume procurement prices of all provinces (regions, cities) across the country , Through the mutual selection between the buyer and the seller, the selected products are determined, and the quantity is subcontracted according to the quantity, and the quantity is purchased.
The first stage is to collect the price data of the declared enterprises.
The applicant company logs on to the "Beijing-Tianjin-Hebei Pharmaceutical Joint Purchasing Platform" to view the company's coronary dilatation balloon product information, and fill in the product price of each registration certificate.
The applicant company logs on to the "Beijing-Tianjin-Hebei Pharmaceutical Joint Purchasing Platform" to view the company's coronary dilatation balloon product information, and fill in the product price of each registration certificate.
For products selected in the purchase of coronary dilatation balloons in other regions, the corresponding selected price should be truthfully filled in; at the same time, the proposed supply price shall not be higher than the lowest price of the product selected in the purchase of volume in other regions.
For the declared product that is not selected in the volume purchase of coronary dilatation balloons in other regions, the proposed supply price shall be directly filled in.
In principle, it shall not be higher than the highest price among the lowest prices selected in the volume purchase of products with the same functional attributes in each region.
In principle, it shall not be higher than the highest price among the lowest prices selected in the volume purchase of products with the same functional attributes in each region.
The second stage is to collect historical purchase data and intended purchase volume of the purchaser.
Procurement entities log on to the "Beijing-Tianjin-Hebei Pharmaceutical Joint Purchasing Platform", and fill in the historical purchase prices and corresponding purchases of all coronary dilatation balloons of the institution in 2019 and 2020, specific to specifications and models.
Procurement entities log on to the "Beijing-Tianjin-Hebei Pharmaceutical Joint Purchasing Platform", and fill in the historical purchase prices and corresponding purchases of all coronary dilatation balloons of the institution in 2019 and 2020, specific to specifications and models.
Refer to the historical procurement volume and procurement catalog, maintain a reasonable ratio with the national organization's centralized procurement of coronary stents, and fill in the procurement demand for coronary dilatation balloon products in the next year, which is specific to the procurement unit.
In order to ensure the seriousness and accuracy of the data filling work, each purchasing entity must upload a letter of authorization confirmed by the purchasing entity's signature when filling relevant data on the platform.
In principle, 80% of the total demand reported by the purchaser shall be taken as the intended purchase amount for this volume-linked procurement and announced.
In principle, 80% of the total demand reported by the purchaser shall be taken as the intended purchase amount for this volume-linked procurement and announced.
The third stage is the two-way selection between the applicant company and the purchasing entity, forming the selected products and subcontracting tasks.
The declaring company confirms its supply intention based on the purchasing entity's intended purchase volume, combined with its own supply capacity.
The declaring company confirms its supply intention based on the purchasing entity's intended purchase volume, combined with its own supply capacity.
The successful selection by both parties is the selected product.
For the applicant company confirming the supply, the selection is successful.
For the declared enterprise that refuses to supply, the corresponding intended purchase amount is regarded as the amount to be allocated, and the purchasing entity is re-allocated to other declared products that meet the conditions and functional attributes.
If it is allocated to the declared product that has been confirmed for supply in the previous round, the enterprise cannot refuse to supply in principle.
, That is, the selection is successful;
For the applicant company confirming the supply, the selection is successful.
For the declared enterprise that refuses to supply, the corresponding intended purchase amount is regarded as the amount to be allocated, and the purchasing entity is re-allocated to other declared products that meet the conditions and functional attributes.
If it is allocated to the declared product that has been confirmed for supply in the previous round, the enterprise cannot refuse to supply in principle.
, That is, the selection is successful;
If the declared products are allocated to the declared products for which the intended purchase volume has not been allocated in the previous round, the declaring enterprise shall continue to confirm the supply intention until all the intended purchase quantities have completed the two-way selection.
The fourth stage is to sign an agreement to implement online procurement.
The purchasing entity, the successful declaring company, and the delivery company determined by the declaring company will sign a tripartite agreement for purchase and sale at the selected price.
The agreement should specify the variety, functional attributes, quantity, price, supply time limit, payment procedure and time, performance method, liability for breach of contract, etc.
The purchasing entity, the successful declaring company, and the delivery company determined by the declaring company will sign a tripartite agreement for purchase and sale at the selected price.
The agreement should specify the variety, functional attributes, quantity, price, supply time limit, payment procedure and time, performance method, liability for breach of contract, etc.
Purchasing entities should strictly implement online procurement of medical consumables in accordance with the requirements of the territorial medical security department.
The actual implementation date of the selected results will be determined by the territorial medical security department.
The actual implementation date of the selected results will be determined by the territorial medical security department.
4.
Or more than 20 provinces will participate
Or more than 20 provinces will participate
How many provinces will participate in the 3+N N? Although it has not been announced yet, the dynamics of many provinces may be able to predict this trend.
In 2020, the Shanxi Provincial Medical Insurance Bureau issued the "Announcement on Further Doing a Good Job in the Inter-provincial Dynamic Linkage of Drugs and Medical Consumables Online Procurement", which pointed out that Beijing-Tianjin-Hebei and 11 provinces will form an alliance.
At present, the "3+6" cross-provincial alliance led by Beijing-Tianjin-Hebei has been brought to the ground for procurement.
9 provinces including Heilongjiang, Jilin, Liaoning, Inner Mongolia, Shanxi, and Shandong have taken the lead in some high-value consumables.
Implement.
9 provinces including Heilongjiang, Jilin, Liaoning, Inner Mongolia, Shanxi, and Shandong have taken the lead in some high-value consumables.
Implement.
It can be seen that the "price net" is accelerating to form, and the price cut storm that has permeated most of the country is already surging and will spread.
For consumables production and distribution companies, the situation can be described as tense.
The previously existing value depressions in the field of high-value consumables will be further filled.
For consumables production and distribution companies, the situation can be described as tense.
The previously existing value depressions in the field of high-value consumables will be further filled.
After the procurement alliance is formed, what actions will it take? Cyberlane uses this Shanxi document to sort out the signals as follows:
On the centralized purchase (negotiation) variety list, the national and provincial alliances select medical consumables in the centralized purchase, and the provincial platform will list the online according to the selected or negotiated price.
The selected medical consumables in the centralized procurement of the city alliances are synchronized on the provincial platform Guiwang.
The selected medical consumables in the centralized procurement of the city alliances are synchronized on the provincial platform Guiwang.
In terms of reference price listing, it will adopt a comprehensive linkage method with the procurement catalogs and prices of 14 provincial alliances such as Tianjin and Shaanxi to carry out reference price listing.
The catalog and price linkage information will be updated dynamically and linked in a timely manner by the Provincial Pharmaceutical Equipment Centralized Procurement Center.
The catalog and price linkage information will be updated dynamically and linked in a timely manner by the Provincial Pharmaceutical Equipment Centralized Procurement Center.
The medicines and medical consumables selected in the centralized procurement of the city alliances will be purchased by the affiliated medical institutions at the online price without bargaining.
5.
The variety of consumables began to expand
The variety of consumables began to expand
On March 12, a red-headed document of the "Notice on the Implementation of the Purchasing Data of Some High-Value Medical Consumables in Hospitals" showed that high-value medical consumables such as artificial joints, spine, and trauma began to fill in data.
It is required to complete the historical procurement data filling work through the "National Organization High-Value Medical Consumables Joint Procurement Platform" within the specified time.
The system will be open from March 13 to March 23.
The system will be open from March 13 to March 23.
From February 22 to 23, Hu Jinglin, director of the National Medical Insurance Administration, led a team to Sichuan Province to conduct research on the centralized procurement of high-value medical consumables.
He listened to the relevant opinions and suggestions of the West China Hospital of Sichuan University, the Provincial Orthopedic Hospital, and the West China Stomatological Hospital of Sichuan University on the collection of orthopedic consumables and oral consumables.
He listened to the relevant opinions and suggestions of the West China Hospital of Sichuan University, the Provincial Orthopedic Hospital, and the West China Stomatological Hospital of Sichuan University on the collection of orthopedic consumables and oral consumables.
On December 3, 2020, according to Xinhua News Agency, the rapid collection of centralized procurement data and price monitoring of the second batch of medical consumables list began, mainly including artificial hip joints, artificial knee joints, defibrillators, occluders, orthopedic materials, There are six categories of staplers.
After the collection, the drop was also amazing.
On November 5, 2020, the national organization announced the results of the planned selection of centralized procurement of high-value medical consumables.
The price of the stent dropped from an average price of about 13,000 yuan to about 700 yuan.
The mainstream products commonly used clinically by medical institutions are basically selected, covering more than 70% of the intended purchases by medical institutions.
The price of the stent dropped from an average price of about 13,000 yuan to about 700 yuan.
The mainstream products commonly used clinically by medical institutions are basically selected, covering more than 70% of the intended purchases by medical institutions.
Compared with 2019, the average price of the same products of the same company has been reduced by 93%, the average price of domestic products has been reduced by 92%, and the average price of imported products has been reduced by 95%.
Based on the amount of intended purchases, it is expected to save 10.
9 billion yuan.
Based on the amount of intended purchases, it is expected to save 10.
9 billion yuan.
Medical institutions actively participate in centralized procurement, with a total of 2,408 medical institutions participating, of which 851 medical institutions with an annual procurement volume of more than 500 participated.
In the first year, the intended purchase volume reached 1.
07 million, which is close to the purchase of drug-loaded chromium alloy stents in 2019 (1.
09 million), accounting for 65% of the total material purchases in 2019 (1.
65 million).
In the first year, the intended purchase volume reached 1.
07 million, which is close to the purchase of drug-loaded chromium alloy stents in 2019 (1.
09 million), accounting for 65% of the total material purchases in 2019 (1.
65 million).
For the decline of coronary dilatation balloons, there have been results in many provinces.
In January 2020, Sichuan and other "six provinces and two districts" inter-provincial alliances issued documents for the procurement of centralized coronary dilatation balloons.
According to the analysis of the Medical Device Dealer Alliance, from the latest results of bids for volume purchases in the 7 provincial alliances including Guangdong, Jiangxi, and Shaanxi, the lowest price for volume purchases has been refreshed.
The historical average price of the selected varieties of expanded balloons in Guangdong Province was 3413.
45 yuan/piece, with an average decrease of 92.
23%, the highest decrease of 96.
34% (124.
9 yuan), and the lowest of 82.
69% (590.
9 yuan); the historical average price of the selected drug balloons in Guangdong Province was 23748.
09 yuan /, the average drop was 44.
45%, the highest drop was 52.
84%, and the lowest drop was 32.
29%.
The historical average price of the selected varieties of expanded balloons in Guangdong Province was 3413.
45 yuan/piece, with an average decrease of 92.
23%, the highest decrease of 96.
34% (124.
9 yuan), and the lowest of 82.
69% (590.
9 yuan); the historical average price of the selected drug balloons in Guangdong Province was 23748.
09 yuan /, the average drop was 44.
45%, the highest drop was 52.
84%, and the lowest drop was 32.
29%.
This time, the Beijing-Tianjin-Hebei "3+N" Alliance Coronary Dilation Balloon Medical Consumables Linkage Procurement Project is still in progress.
Cyberlane will continue to pay attention.
The price list below may be the future price trend.
Reference.
Cyberlane will continue to pay attention.
The price list below may be the future price trend.
Reference.
Before the news of the medical network on March 15th, there are coronary stents, existing coronary dilatation balloons, and consumables such as artificial joints, spine and trauma are also on the way to collect.
.
.
.
.
1.
Start quotation
Start quotation
On March 13, Beijing Medical Centralized Purchasing Service Center, Tianjin Medical Purchasing Center, Hebei Medical Drugs and Equipment Centralized Purchasing Center jointly issued the "About the Convening of the Beijing-Tianjin-Hebei "3+N" Alliance Coronary Dilation Balloon Medical Consumables According to the notice of the "Communication Meeting of Enterprises for Procurement with Volume ", it is pointed out for all relevant companies that in order to do a good job in the procurement of medical consumables for coronary dilatation balloons in the Beijing-Tianjin-Hebei "3+N" alliance, it will be scheduled for March 2021 A corporate communication meeting was held on the 16th.
Notice that intends to participate in the Beijing, Tianjin and "3 + N" class alliance coronary balloon dilatation joint procurement of medical supplies with the amount of domestic or imported supplies manufacturer supplies the total domestic pharmnet.
com.
cn/agent_product/" target="_blank">agents , each company can send up to two delegates.
com.
cn/agent_product/" target="_blank">agents , each company can send up to two delegates.
At present, the official agency has started the collection of the price of coronary dilatation balloons from various related companies.
In view of the fact that the relevant companies have been in accordance with the Tianjin Medical Purchasing Center's March 9th "Notice on Carrying out the Centralized Filling of Information on Coronary Dilatation Balloon Medical Consumables" Fill in the price information;
In view of the fact that the relevant companies have been in accordance with the Tianjin Medical Purchasing Center's March 9th "Notice on Carrying out the Centralized Filling of Information on Coronary Dilatation Balloon Medical Consumables" Fill in the price information;
The alliance’s regional research decided to introduce the reported price to the “3+N” Alliance of Beijing-Tianjin-Hebei “3+N” Alliance Coronary Dilation Balloon Medical Consumables Linkage Purchase Project.
In principle, the price information declared by relevant companies in the previous period is the proposed supply price in the Beijing-Tianjin-Hebei "3+N" alliance area.
In principle, the price information declared by relevant companies in the previous period is the proposed supply price in the Beijing-Tianjin-Hebei "3+N" alliance area.
For companies that did not participate in the centralized reporting of price information in the previous period, they can supplement the report before 12:00 on March 14.
The supplementary price information and the earlier-filled price information will be imported into the Beijing-Tianjin-Hebei "3+N" Alliance Coronary Dilation Balloon Medical Consumables Cooperative Procurement Project.
The supplementary price information and the earlier-filled price information will be imported into the Beijing-Tianjin-Hebei "3+N" Alliance Coronary Dilation Balloon Medical Consumables Cooperative Procurement Project.
2.
The inter-provincial alliance is launched
The inter-provincial alliance is launched
On March 12, the official release of the "Notice on Carrying out the Related Work of the Beijing-Tianjin-Hebei "3+N" Alliance Coronary Expansion Balloon Medical Consumables Procurement Project".
Balloon, the structure is rapid exchange type, the first 15 digits of the National Medical Insurance Bureau medical insurance medical consumables code are C02020500200001 or C02020500200003, and the functional attributes include semi-compliant and non-compliant.
Balloon, the structure is rapid exchange type, the first 15 digits of the National Medical Insurance Bureau medical insurance medical consumables code are C02020500200001 or C02020500200003, and the functional attributes include semi-compliant and non-compliant.
Purchasing units are distinguished according to registration certificates and functional attributes.
The same purchasing unit includes all specifications and models.
The same purchasing unit includes all specifications and models.
In terms of procurement subjects, all public medical institutions (including military medical institutions) in Beijing, Tianjin, Hebei, Xinjiang, and the Corps formed a procurement alliance to implement joint procurement by volume.
Encourage medical insurance designated social medical institutions to actively participate.
Support the participation of medical institutions from other provinces (autonomous regions and municipalities) of the "3+N" Pharmaceutical Joint Procurement Alliance.
Encourage medical insurance designated social medical institutions to actively participate.
Support the participation of medical institutions from other provinces (autonomous regions and municipalities) of the "3+N" Pharmaceutical Joint Procurement Alliance.
The Beijing-Tianjin-Hebei Purchasing Center, as an agency for the procurement of coronary dilatation balloon medical consumables, relies on the Beijing-Tianjin-Hebei Pharmaceutical Joint Procurement Platform to be responsible for the specific implementation of project procurement.
The local medical security departments are responsible for formulating and implementing the implementation of the results of the territorial selection and supporting policies.
The local medical security departments are responsible for formulating and implementing the implementation of the results of the territorial selection and supporting policies.
This time, the procurement cycle of centralized delivery of coronary dilatation balloons is aligned with the procurement cycle of centralized delivery of coronary stents organized by the state.
The purchase agreement is signed for the first time for one year, and the purchase amount for renewal of the purchase agreement is determined on a pro rata basis in principle.
The purchase agreement is signed for the first time for one year, and the purchase amount for renewal of the purchase agreement is determined on a pro rata basis in principle.
During the purchase cycle, the purchaser will give priority to the use of this coronary dilatation balloon to purchase the selected products, and ensure that the agreed purchase amount is completed.
On this basis, the purchaser can purchase other appropriate coronary dilatation balloon products in an appropriate amount according to the relevant regulations of the province's centralized procurement management of medical consumables.
On this basis, the purchaser can purchase other appropriate coronary dilatation balloon products in an appropriate amount according to the relevant regulations of the province's centralized procurement management of medical consumables.
During the procurement cycle, the procurement entity completes the current contracted procurement volume, and the selected company still needs to supply the selected price at the selected price until the expiration of the procurement cycle.
During the procurement cycle, if the selected price for volume purchases in other regions is lower than the price selected for this volume linkage purchase, price linkage will be implemented.
During the procurement cycle, if the selected price for volume purchases in other regions is lower than the price selected for this volume linkage purchase, price linkage will be implemented.
3.
Linkage with prices in all provinces (autonomous regions and municipalities) across the country
Linkage with prices in all provinces (autonomous regions and municipalities) across the country
This time, the centralized procurement method of coronary dilatation balloons is volume linkage and two-way selection, that is, based on the use needs of the purchaser, referring to the overall market price level, comprehensive quality and other factors, linking the volume procurement prices of all provinces (regions, cities) across the country , Through the mutual selection between the buyer and the seller, the selected products are determined, and the quantity is subcontracted according to the quantity, and the quantity is purchased.
The first stage is to collect the price data of the declared enterprises.
The applicant company logs on to the "Beijing-Tianjin-Hebei Pharmaceutical Joint Purchasing Platform" to view the company's coronary dilatation balloon product information, and fill in the product price of each registration certificate.
The applicant company logs on to the "Beijing-Tianjin-Hebei Pharmaceutical Joint Purchasing Platform" to view the company's coronary dilatation balloon product information, and fill in the product price of each registration certificate.
For products selected in the purchase of coronary dilatation balloons in other regions, the corresponding selected price should be truthfully filled in; at the same time, the proposed supply price shall not be higher than the lowest price of the product selected in the purchase of volume in other regions.
For the declared product that is not selected in the volume purchase of coronary dilatation balloons in other regions, the proposed supply price shall be directly filled in.
In principle, it shall not be higher than the highest price among the lowest prices selected in the volume purchase of products with the same functional attributes in each region.
In principle, it shall not be higher than the highest price among the lowest prices selected in the volume purchase of products with the same functional attributes in each region.
The second stage is to collect historical purchase data and intended purchase volume of the purchaser.
Procurement entities log on to the "Beijing-Tianjin-Hebei Pharmaceutical Joint Purchasing Platform", and fill in the historical purchase prices and corresponding purchases of all coronary dilatation balloons of the institution in 2019 and 2020, specific to specifications and models.
Procurement entities log on to the "Beijing-Tianjin-Hebei Pharmaceutical Joint Purchasing Platform", and fill in the historical purchase prices and corresponding purchases of all coronary dilatation balloons of the institution in 2019 and 2020, specific to specifications and models.
Refer to the historical procurement volume and procurement catalog, maintain a reasonable ratio with the national organization's centralized procurement of coronary stents, and fill in the procurement demand for coronary dilatation balloon products in the next year, which is specific to the procurement unit.
In order to ensure the seriousness and accuracy of the data filling work, each purchasing entity must upload a letter of authorization confirmed by the purchasing entity's signature when filling relevant data on the platform.
In principle, 80% of the total demand reported by the purchaser shall be taken as the intended purchase amount for this volume-linked procurement and announced.
In principle, 80% of the total demand reported by the purchaser shall be taken as the intended purchase amount for this volume-linked procurement and announced.
The third stage is the two-way selection between the applicant company and the purchasing entity, forming the selected products and subcontracting tasks.
The declaring company confirms its supply intention based on the purchasing entity's intended purchase volume, combined with its own supply capacity.
The declaring company confirms its supply intention based on the purchasing entity's intended purchase volume, combined with its own supply capacity.
The successful selection by both parties is the selected product.
For the applicant company confirming the supply, the selection is successful.
For the declared enterprise that refuses to supply, the corresponding intended purchase amount is regarded as the amount to be allocated, and the purchasing entity is re-allocated to other declared products that meet the conditions and functional attributes.
If it is allocated to the declared product that has been confirmed for supply in the previous round, the enterprise cannot refuse to supply in principle.
, That is, the selection is successful;
For the applicant company confirming the supply, the selection is successful.
For the declared enterprise that refuses to supply, the corresponding intended purchase amount is regarded as the amount to be allocated, and the purchasing entity is re-allocated to other declared products that meet the conditions and functional attributes.
If it is allocated to the declared product that has been confirmed for supply in the previous round, the enterprise cannot refuse to supply in principle.
, That is, the selection is successful;
If the declared products are allocated to the declared products for which the intended purchase volume has not been allocated in the previous round, the declaring enterprise shall continue to confirm the supply intention until all the intended purchase quantities have completed the two-way selection.
The fourth stage is to sign an agreement to implement online procurement.
The purchasing entity, the successful declaring company, and the delivery company determined by the declaring company will sign a tripartite agreement for purchase and sale at the selected price.
The agreement should specify the variety, functional attributes, quantity, price, supply time limit, payment procedure and time, performance method, liability for breach of contract, etc.
The purchasing entity, the successful declaring company, and the delivery company determined by the declaring company will sign a tripartite agreement for purchase and sale at the selected price.
The agreement should specify the variety, functional attributes, quantity, price, supply time limit, payment procedure and time, performance method, liability for breach of contract, etc.
Purchasing entities should strictly implement online procurement of medical consumables in accordance with the requirements of the territorial medical security department.
The actual implementation date of the selected results will be determined by the territorial medical security department.
The actual implementation date of the selected results will be determined by the territorial medical security department.
4.
Or more than 20 provinces will participate
Or more than 20 provinces will participate
How many provinces will participate in the 3+N N? Although it has not been announced yet, the dynamics of many provinces may be able to predict this trend.
In 2020, the Shanxi Provincial Medical Insurance Bureau issued the "Announcement on Further Doing a Good Job in the Inter-provincial Dynamic Linkage of Drugs and Medical Consumables Online Procurement", which pointed out that Beijing-Tianjin-Hebei and 11 provinces will form an alliance.
At present, the "3+6" cross-provincial alliance led by Beijing-Tianjin-Hebei has been brought to the ground for procurement.
9 provinces including Heilongjiang, Jilin, Liaoning, Inner Mongolia, Shanxi, and Shandong have taken the lead in some high-value consumables.
Implement.
9 provinces including Heilongjiang, Jilin, Liaoning, Inner Mongolia, Shanxi, and Shandong have taken the lead in some high-value consumables.
Implement.
It can be seen that the "price net" is accelerating to form, and the price cut storm that has permeated most of the country is already surging and will spread.
For consumables production and distribution companies, the situation can be described as tense.
The previously existing value depressions in the field of high-value consumables will be further filled.
For consumables production and distribution companies, the situation can be described as tense.
The previously existing value depressions in the field of high-value consumables will be further filled.
After the procurement alliance is formed, what actions will it take? Cyberlane uses this Shanxi document to sort out the signals as follows:
On the centralized purchase (negotiation) variety list, the national and provincial alliances select medical consumables in the centralized purchase, and the provincial platform will list the online according to the selected or negotiated price.
The selected medical consumables in the centralized procurement of the city alliances are synchronized on the provincial platform Guiwang.
The selected medical consumables in the centralized procurement of the city alliances are synchronized on the provincial platform Guiwang.
In terms of reference price listing, it will adopt a comprehensive linkage method with the procurement catalogs and prices of 14 provincial alliances such as Tianjin and Shaanxi to carry out reference price listing.
The catalog and price linkage information will be updated dynamically and linked in a timely manner by the Provincial Pharmaceutical Equipment Centralized Procurement Center.
The catalog and price linkage information will be updated dynamically and linked in a timely manner by the Provincial Pharmaceutical Equipment Centralized Procurement Center.
The medicines and medical consumables selected in the centralized procurement of the city alliances will be purchased by the affiliated medical institutions at the online price without bargaining.
5.
The variety of consumables began to expand
The variety of consumables began to expand
On March 12, a red-headed document of the "Notice on the Implementation of the Purchasing Data of Some High-Value Medical Consumables in Hospitals" showed that high-value medical consumables such as artificial joints, spine, and trauma began to fill in data.
It is required to complete the historical procurement data filling work through the "National Organization High-Value Medical Consumables Joint Procurement Platform" within the specified time.
The system will be open from March 13 to March 23.
The system will be open from March 13 to March 23.
From February 22 to 23, Hu Jinglin, director of the National Medical Insurance Administration, led a team to Sichuan Province to conduct research on the centralized procurement of high-value medical consumables.
He listened to the relevant opinions and suggestions of the West China Hospital of Sichuan University, the Provincial Orthopedic Hospital, and the West China Stomatological Hospital of Sichuan University on the collection of orthopedic consumables and oral consumables.
He listened to the relevant opinions and suggestions of the West China Hospital of Sichuan University, the Provincial Orthopedic Hospital, and the West China Stomatological Hospital of Sichuan University on the collection of orthopedic consumables and oral consumables.
On December 3, 2020, according to Xinhua News Agency, the rapid collection of centralized procurement data and price monitoring of the second batch of medical consumables list began, mainly including artificial hip joints, artificial knee joints, defibrillators, occluders, orthopedic materials, There are six categories of staplers.
After the collection, the drop was also amazing.
On November 5, 2020, the national organization announced the results of the planned selection of centralized procurement of high-value medical consumables.
The price of the stent dropped from an average price of about 13,000 yuan to about 700 yuan.
The mainstream products commonly used clinically by medical institutions are basically selected, covering more than 70% of the intended purchases by medical institutions.
The price of the stent dropped from an average price of about 13,000 yuan to about 700 yuan.
The mainstream products commonly used clinically by medical institutions are basically selected, covering more than 70% of the intended purchases by medical institutions.
Compared with 2019, the average price of the same products of the same company has been reduced by 93%, the average price of domestic products has been reduced by 92%, and the average price of imported products has been reduced by 95%.
Based on the amount of intended purchases, it is expected to save 10.
9 billion yuan.
Based on the amount of intended purchases, it is expected to save 10.
9 billion yuan.
Medical institutions actively participate in centralized procurement, with a total of 2,408 medical institutions participating, of which 851 medical institutions with an annual procurement volume of more than 500 participated.
In the first year, the intended purchase volume reached 1.
07 million, which is close to the purchase of drug-loaded chromium alloy stents in 2019 (1.
09 million), accounting for 65% of the total material purchases in 2019 (1.
65 million).
In the first year, the intended purchase volume reached 1.
07 million, which is close to the purchase of drug-loaded chromium alloy stents in 2019 (1.
09 million), accounting for 65% of the total material purchases in 2019 (1.
65 million).
For the decline of coronary dilatation balloons, there have been results in many provinces.
In January 2020, Sichuan and other "six provinces and two districts" inter-provincial alliances issued documents for the procurement of centralized coronary dilatation balloons.
According to the analysis of the Medical Device Dealer Alliance, from the latest results of bids for volume purchases in the 7 provincial alliances including Guangdong, Jiangxi, and Shaanxi, the lowest price for volume purchases has been refreshed.
The historical average price of the selected varieties of expanded balloons in Guangdong Province was 3413.
45 yuan/piece, with an average decrease of 92.
23%, the highest decrease of 96.
34% (124.
9 yuan), and the lowest of 82.
69% (590.
9 yuan); the historical average price of the selected drug balloons in Guangdong Province was 23748.
09 yuan /, the average drop was 44.
45%, the highest drop was 52.
84%, and the lowest drop was 32.
29%.
The historical average price of the selected varieties of expanded balloons in Guangdong Province was 3413.
45 yuan/piece, with an average decrease of 92.
23%, the highest decrease of 96.
34% (124.
9 yuan), and the lowest of 82.
69% (590.
9 yuan); the historical average price of the selected drug balloons in Guangdong Province was 23748.
09 yuan /, the average drop was 44.
45%, the highest drop was 52.
84%, and the lowest drop was 32.
29%.
This time, the Beijing-Tianjin-Hebei "3+N" Alliance Coronary Dilation Balloon Medical Consumables Linkage Procurement Project is still in progress.
Cyberlane will continue to pay attention.
The price list below may be the future price trend.
Reference.
Cyberlane will continue to pay attention.
The price list below may be the future price trend.
Reference.
Before the news of the medical network on March 15th, there are coronary stents, existing coronary dilatation balloons, and consumables such as artificial joints, spine and trauma are also on the way to collect.
.
.
.
.
1.
Start quotation
1. Start quotation
Start quotation
On March 13, Beijing Medical Centralized Purchasing Service Center, Tianjin Medical Purchasing Center, Hebei Medical Drugs and Equipment Centralized Purchasing Center jointly issued the "About the Convening of the Beijing-Tianjin-Hebei "3+N" Alliance Coronary Dilation Balloon Medical Consumables According to the notice of the "Communication Meeting of Enterprises for Procurement with Volume ", it is pointed out for all relevant companies that in order to do a good job in the procurement of medical consumables for coronary dilatation balloons in the Beijing-Tianjin-Hebei "3+N" alliance, it will be scheduled for March 2021 A corporate communication meeting was held on the 16th.
Drugs Drugs Drugs enterprise business enterprise Notice that intends to participate in the Beijing, Tianjin and "3 + N" class alliance coronary balloon dilatation joint procurement of medical supplies with the amount of domestic or imported supplies manufacturer supplies the total domestic pharmnet.
com.
cn/agent_product/" target="_blank">agents , each company can send up to two delegates.
pharmnet. com.
cn/agent_product/" target="_blank">agents , each company can send up to two delegates.
com.
cn/agent_product/" target="_blank">Agentpharmnet.
com.
cn/agent_product/" target="_blank"> Agent Agent
At present, the official agency has started the collection of the price of coronary dilatation balloons from various related companies.
In view of the fact that the relevant companies have been in accordance with the Tianjin Medical Purchasing Center's March 9th "Notice on Carrying out the Centralized Filling of Information on Coronary Dilatation Balloon Medical Consumables" Fill in the price information;
Medicine Medicine MedicineIn view of the fact that the relevant companies have been in accordance with the Tianjin Medical Purchasing Center's March 9th "Notice on Carrying out the Centralized Filling of Information on Coronary Dilatation Balloon Medical Consumables" Fill in the price information;
The alliance’s regional research decided to introduce the reported price to the “3+N” Alliance of Beijing-Tianjin-Hebei “3+N” Alliance Coronary Dilation Balloon Medical Consumables Linkage Purchase Project.
In principle, the price information declared by relevant companies in the previous period is the proposed supply price in the Beijing-Tianjin-Hebei "3+N" alliance area.
In principle, the price information declared by relevant companies in the previous period is the proposed supply price in the Beijing-Tianjin-Hebei "3+N" alliance area.
For companies that did not participate in the centralized reporting of price information in the previous period, they can supplement the report before 12:00 on March 14.
The supplementary price information and the earlier-filled price information will be imported into the Beijing-Tianjin-Hebei "3+N" Alliance Coronary Dilation Balloon Medical Consumables Cooperative Procurement Project.
The supplementary price information and the earlier-filled price information will be imported into the Beijing-Tianjin-Hebei "3+N" Alliance Coronary Dilation Balloon Medical Consumables Cooperative Procurement Project.
2.
The inter-provincial alliance is launched
2. The inter-provincial alliance is launched
The inter-provincial alliance is launched
On March 12, the official release of the "Notice on Carrying out the Related Work of the Beijing-Tianjin-Hebei "3+N" Alliance Coronary Expansion Balloon Medical Consumables Procurement Project".
Balloon, the structure is rapid exchange type, the first 15 digits of the National Medical Insurance Bureau medical insurance medical consumables code are C02020500200001 or C02020500200003, and the functional attributes include semi-compliant and non-compliant.
Balloon, the structure is rapid exchange type, the first 15 digits of the National Medical Insurance Bureau medical insurance medical consumables code are C02020500200001 or C02020500200003, and the functional attributes include semi-compliant and non-compliant.
Purchasing units are distinguished according to registration certificates and functional attributes.
The same purchasing unit includes all specifications and models.
The same purchasing unit includes all specifications and models.
In terms of procurement subjects, all public medical institutions (including military medical institutions) in Beijing, Tianjin, Hebei, Xinjiang, and the Corps formed a procurement alliance to implement joint procurement by volume.
Encourage medical insurance designated social medical institutions to actively participate.
Support the participation of medical institutions from other provinces (autonomous regions and municipalities) of the "3+N" Pharmaceutical Joint Procurement Alliance.
Encourage medical insurance designated social medical institutions to actively participate.
Support the participation of medical institutions from other provinces (autonomous regions and municipalities) of the "3+N" Pharmaceutical Joint Procurement Alliance.
The Beijing-Tianjin-Hebei Purchasing Center, as an agency for the procurement of coronary dilatation balloon medical consumables, relies on the Beijing-Tianjin-Hebei Pharmaceutical Joint Procurement Platform to be responsible for the specific implementation of project procurement.
The local medical security departments are responsible for formulating and implementing the implementation of the results of the territorial selection and supporting policies.
The local medical security departments are responsible for formulating and implementing the implementation of the results of the territorial selection and supporting policies.
This time, the procurement cycle of centralized delivery of coronary dilatation balloons is aligned with the procurement cycle of centralized delivery of coronary stents organized by the state.
The purchase agreement is signed for the first time for one year, and the purchase amount for renewal of the purchase agreement is determined on a pro rata basis in principle.
The purchase agreement is signed for the first time for one year, and the purchase amount for renewal of the purchase agreement is determined on a pro rata basis in principle.
During the purchase cycle, the purchaser will give priority to the use of this coronary dilatation balloon to purchase the selected products, and ensure that the agreed purchase amount is completed.
On this basis, the purchaser can purchase other appropriate coronary dilatation balloon products in an appropriate amount according to the relevant regulations of the province's centralized procurement management of medical consumables.
On this basis, the purchaser can purchase other appropriate coronary dilatation balloon products in an appropriate amount according to the relevant regulations of the province's centralized procurement management of medical consumables.
During the procurement cycle, the procurement entity completes the current contracted procurement volume, and the selected company still needs to supply the selected price at the selected price until the expiration of the procurement cycle.
During the procurement cycle, if the selected price for volume purchases in other regions is lower than the price selected for this volume linkage purchase, price linkage will be implemented.
During the procurement cycle, if the selected price for volume purchases in other regions is lower than the price selected for this volume linkage purchase, price linkage will be implemented.
3.
Linkage with prices in all provinces (autonomous regions and municipalities) across the country
3. Linkage with prices in all provinces (autonomous regions and municipalities) across the country
Linkage with prices in all provinces (autonomous regions and municipalities) across the country
This time, the centralized procurement method of coronary dilatation balloons is volume linkage and two-way selection, that is, based on the use needs of the purchaser, referring to the overall market price level, comprehensive quality and other factors, linking the volume procurement prices of all provinces (regions, cities) across the country , Through the mutual selection between the buyer and the seller, the selected products are determined, and the quantity is subcontracted according to the quantity, and the quantity is purchased.
The first stage is to collect the price data of the declared enterprises.
The applicant company logs on to the "Beijing-Tianjin-Hebei Pharmaceutical Joint Purchasing Platform" to view the company's coronary dilatation balloon product information, and fill in the product price of each registration certificate.
The applicant company logs on to the "Beijing-Tianjin-Hebei Pharmaceutical Joint Purchasing Platform" to view the company's coronary dilatation balloon product information, and fill in the product price of each registration certificate.
For products selected in the purchase of coronary dilatation balloons in other regions, the corresponding selected price should be truthfully filled in; at the same time, the proposed supply price shall not be higher than the lowest price of the product selected in the purchase of volume in other regions.
For the declared product that is not selected in the volume purchase of coronary dilatation balloons in other regions, the proposed supply price shall be directly filled in.
In principle, it shall not be higher than the highest price among the lowest prices selected in the volume purchase of products with the same functional attributes in each region.
In principle, it shall not be higher than the highest price among the lowest prices selected in the volume purchase of products with the same functional attributes in each region.
The second stage is to collect historical purchase data and intended purchase volume of the purchaser.
Procurement entities log on to the "Beijing-Tianjin-Hebei Pharmaceutical Joint Purchasing Platform", and fill in the historical purchase prices and corresponding purchases of all coronary dilatation balloons of the institution in 2019 and 2020, specific to specifications and models.
Procurement entities log on to the "Beijing-Tianjin-Hebei Pharmaceutical Joint Purchasing Platform", and fill in the historical purchase prices and corresponding purchases of all coronary dilatation balloons of the institution in 2019 and 2020, specific to specifications and models.
Refer to the historical procurement volume and procurement catalog, maintain a reasonable ratio with the national organization's centralized procurement of coronary stents, and fill in the procurement demand for coronary dilatation balloon products in the next year, which is specific to the procurement unit.
In order to ensure the seriousness and accuracy of the data filling work, each purchasing entity must upload a letter of authorization confirmed by the purchasing entity's signature when filling relevant data on the platform.
In principle, 80% of the total demand reported by the purchaser shall be taken as the intended purchase amount for this volume-linked procurement and announced.
In principle, 80% of the total demand reported by the purchaser shall be taken as the intended purchase amount for this volume-linked procurement and announced.
The third stage is the two-way selection between the applicant company and the purchasing entity, forming the selected products and subcontracting tasks.
The declaring company confirms its supply intention based on the purchasing entity's intended purchase volume, combined with its own supply capacity.
The declaring company confirms its supply intention based on the purchasing entity's intended purchase volume, combined with its own supply capacity.
The successful selection by both parties is the selected product.
For the applicant company confirming the supply, the selection is successful.
For the declared enterprise that refuses to supply, the corresponding intended purchase amount is regarded as the amount to be allocated, and the purchasing entity is re-allocated to other declared products that meet the conditions and functional attributes.
If it is allocated to the declared product that has been confirmed for supply in the previous round, the enterprise cannot refuse to supply in principle.
, That is, the selection is successful;
For the applicant company confirming the supply, the selection is successful.
For the declared enterprise that refuses to supply, the corresponding intended purchase amount is regarded as the amount to be allocated, and the purchasing entity is re-allocated to other declared products that meet the conditions and functional attributes.
If it is allocated to the declared product that has been confirmed for supply in the previous round, the enterprise cannot refuse to supply in principle.
, That is, the selection is successful;
If the declared products are allocated to the declared products for which the intended purchase volume has not been allocated in the previous round, the declaring enterprise shall continue to confirm the supply intention until all the intended purchase quantities have completed the two-way selection.
The fourth stage is to sign an agreement to implement online procurement.
The purchasing entity, the successful declaring company, and the delivery company determined by the declaring company will sign a tripartite agreement for purchase and sale at the selected price.
The agreement should specify the variety, functional attributes, quantity, price, supply time limit, payment procedure and time, performance method, liability for breach of contract, etc.
The purchasing entity, the successful declaring company, and the delivery company determined by the declaring company will sign a tripartite agreement for purchase and sale at the selected price.
The agreement should specify the variety, functional attributes, quantity, price, supply time limit, payment procedure and time, performance method, liability for breach of contract, etc.
Purchasing entities should strictly implement online procurement of medical consumables in accordance with the requirements of the territorial medical security department.
The actual implementation date of the selected results will be determined by the territorial medical security department.
The actual implementation date of the selected results will be determined by the territorial medical security department.
4.
Or more than 20 provinces will participate
4. Or more than 20 provinces will participate
Or more than 20 provinces will participate
How many provinces will participate in the 3+N N? Although it has not been announced yet, the dynamics of many provinces may be able to predict this trend.
In 2020, the Shanxi Provincial Medical Insurance Bureau issued the "Announcement on Further Doing a Good Job in the Inter-provincial Dynamic Linkage of Drugs and Medical Consumables Online Procurement", which pointed out that Beijing-Tianjin-Hebei and 11 provinces will form an alliance.
At present, the "3+6" cross-provincial alliance led by Beijing-Tianjin-Hebei has been brought to the ground for procurement.
9 provinces including Heilongjiang, Jilin, Liaoning, Inner Mongolia, Shanxi, and Shandong have taken the lead in some high-value consumables.
Implement.
9 provinces including Heilongjiang, Jilin, Liaoning, Inner Mongolia, Shanxi, and Shandong have taken the lead in some high-value consumables.
Implement.
It can be seen that the "price net" is accelerating to form, and the price cut storm that has permeated most of the country is already surging and will spread.
For consumables production and distribution companies, the situation can be described as tense.
The previously existing value depressions in the field of high-value consumables will be further filled.
For consumables production and distribution companies, the situation can be described as tense.
The previously existing value depressions in the field of high-value consumables will be further filled.
After the procurement alliance is formed, what actions will it take? Cyberlane uses this Shanxi document to sort out the signals as follows:
On the centralized purchase (negotiation) variety list, the national and provincial alliances select medical consumables in the centralized purchase, and the provincial platform will list the online according to the selected or negotiated price.
The selected medical consumables in the centralized procurement of the city alliances are synchronized on the provincial platform Guiwang.
The selected medical consumables in the centralized procurement of the city alliances are synchronized on the provincial platform Guiwang.
，14。。
，。
5、
5、 312，《》，、、。
“”，313323。
22223，。、、。
2020123，，，、、、、、。
，。
2020115，。1.
3700。，70%。
3700。，70%。
2019，93%，92%，95%，，109。
，2408，500851。107，2019（109），2019（165）65%。
，。
20201，“”。
，、、7，。3413.
45/，92.
23%，96.
34%（124.
9），82.
69%（590.
9）；23748.
09/，44.
45%，52.
84%，32.
29%。
45/，92.
23%，96.
34%（124.
9），82.
69%（590.
9）；23748.
09/，44.
45%，52.
84%，32.
29%。
，“3+N”，，。
